PLCE1 | Phospholipase C, epsilon 1 | Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
PLCG1 | Phospholipase C, gamma 1 | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PLCG2 | Phospholipase C, gamma 2 (phosphatidylinositol-specific) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
PLD2 | Phospholipase D2 | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PRKACA | Protein kinase, cAMP-dependent, catalytic, alpha | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PRKACB | Protein kinase, cAMP-dependent, catalytic, beta | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKCG | Protein kinase C, gamma | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Tissue enriched |
PTPN11 | Protein tyrosine phosphatase, non-receptor type 11 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
RAB5B | RAB5B, member RAS oncogene family | RAS pathway related proteins
| | | | | Expressed in all |
RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
RASA2 | RAS p21 protein activator 2 | Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
RASAL1 | RAS protein activator like 1 (GAP1 like) | Plasma proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RASAL3 | RAS protein activator like 3 | RAS pathway related proteins
| | | | | Tissue enhanced |
RASGRF2 | Ras protein-specific guanine nucleotide-releasing factor 2 | RAS pathway related proteins
| | | | | Mixed |
RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | RAS pathway related proteins
| | | | | Expressed in all |
RELA | V-rel avian reticuloendotheliosis viral oncogene homolog A | Cancer-related genes Disease related genes RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
RRAS2 | Related RAS viral (r-ras) oncogene homolog 2 | Disease related genes RAS pathway related proteins
| | | | | Expressed in all |
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | Mitochondrial proteins RAS pathway related proteins
| | | | | Expressed in all |
SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | Plasma proteins RAS pathway related proteins
| | | | | Group enriched |
VEGFA | Vascular endothelial growth factor A | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
ZAP70 | Zeta-chain (TCR) associated protein kinase 70kDa | Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Tissue enhanced |